18 results

• Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

  June 3, 2022

  Irvin Jackson

  The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.

• Tagrisso Side Effects Linked to Potentially Deadly Skin Reactions: Case Report

  May 3, 2022

  Irvin Jackson

  A case report warns of potentially extreme and deadly skin reactions linked to use of the cancer drug Tagrisso.

• Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

  February 4, 2022

  Irvin Jackson

  The FDA warns that the relatively new cancer drug, Ukoniq, may increase the risk of death in the lymphoma patients it was designed to treat.

• Teva Mold Contamination Problems Result in Recall for 2.5M Drug Vials, Shut Down of California Plant

  October 5, 2021

  Irvin Jackson

  Teva has recently shut down a California manufacturing facility after recalling 2.5 million vials of unidentified drugs which may have had mold contamination.

• Risk of Peripheral Neuropathy From Abraxane, Eloxatin, Increased By Certain Risk Factors: Study

  February 16, 2021

  Martha Garcia

  A new study appears to identify factors which increase the risk of peripheral neuropathy linked to the use of some cancer drugs.

• Side Effects of Lynparza, Rubraca, Similar Cancer Drugs May Increase Risk Of Leukemia: Study

  January 6, 2021

  Irvin Jackson

  A new study reveals a link between some ovarian cancer drugs and an increased risk of blood cancers, like leukemia.

• Imbruvica Toxic Side Effects Should Lead FDA to Require Additional Studies To Evaluate Risks: Report

  December 2, 2020

  Russell Maas

  Some doctors warn the cancer drug Imbruvica appears to have toxic side effects which can result in heart rhythm problems and death.

• FDA Approves Opdivo, Yervoy Drug Combo To Treat Mesothelioma

  October 5, 2020

  Irvin Jackson

  The FDA has approved the use of a drug combination of Opdivo and Yervoy as a first-line treatment for mesothelioma.